AC
INSIDER · VRXA · Veraxa Biotech AG - Post de-SPAC · CHIEF EXECUTIVE OFFICER
Antz Christoph Rudiger
Every open-market transaction filed under this name, Aug 27 to Aug 27.
Filings
1
1 buy · 0 sells
Bought
$8K
open market, at cost
Sold
—
includes scheduled sales
Buys since
−8.5%
avg move from buy price, 1 priced
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Aug 27 | VRXA | Veraxa Biotech AG - Post de-SPAC | Chief Executive Officer | Buy | 5,000 | $1.53 | $8K | −8.5% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.